Technical Analysis for TRYPF - Tryp Therapeutics Inc

Grade Last Price % Change Price Change
F 0.4602 -2.97% -0.0141
TRYPF closed down 2.97 percent on Friday, June 18, 2021, on 52 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical TRYPF trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Pocket Pivot Bullish Swing Setup -2.97%
Outside Day Range Expansion -2.97%
Wide Bands Range Expansion -2.97%
Oversold Stochastic Weakness -2.97%
Outside Day Range Expansion -2.79%
Wide Bands Range Expansion -2.79%
Oversold Stochastic Weakness -2.79%
Older End-of-Day Signals for TRYPF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 5 days ago
Down 2% 5 days ago
Down 1% 5 days ago
Fell Below Previous Day's Low 5 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tryp Therapeutics Inc Description

Tryp Therapeutics Inc., a clinical stage pharmaceutical company, focuses on developing compounds with known activity and/or safety profiles for the treatment of rare or orphan diseases and other diseases. The company's lead development program is psilocybin-for-neuropsychiatry (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 for fibromyalgia, hyperphagia in prader-willi syndrome, and other therapies; and TRP-1001, an oral formulation of razoxane evaluating for the treatment of soft tissue sarcoma. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. The company was founded in 2019 and is headquartered in Kelowna, Canada.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Diseases Neurology Stage Pharmaceutical Fibromyalgia Orphan Diseases Soft Tissue Sarcoma Treatment Of Bipolar Disorder

Is TRYPF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.9895
52 Week Low 0.45
Average Volume 76,287
200-Day Moving Average 0.0000
50-Day Moving Average 0.5494
20-Day Moving Average 0.5221
10-Day Moving Average 0.4853
Average True Range 0.0391
ADX 19.17
+DI 12.0438
-DI 19.7080
Chandelier Exit (Long, 3 ATRs) 0.5287
Chandelier Exit (Short, 3 ATRs) 0.5726
Upper Bollinger Bands 0.6117
Lower Bollinger Band 0.4325
Percent B (%b) 0.15
BandWidth 34.3229
MACD Line -0.0293
MACD Signal Line -0.0244
MACD Histogram -0.0049
Fundamentals Value
Market Cap 30.52 Million
Num Shares 66.3 Million
EPS
Price-to-Sales 0.00
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.5156
Resistance 3 (R3) 0.5201 0.5061 0.5063
Resistance 2 (R2) 0.5061 0.4920 0.5039 0.5032
Resistance 1 (R1) 0.4832 0.4833 0.4762 0.4787 0.5002
Pivot Point 0.4692 0.4692 0.4658 0.4670 0.4692
Support 1 (S1) 0.4463 0.4551 0.4393 0.4418 0.4202
Support 2 (S2) 0.4323 0.4464 0.4301 0.4172
Support 3 (S3) 0.4094 0.4323 0.4141
Support 4 (S4) 0.4049